These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Low-dose naltrexone: a novel treatment for Hailey-Hailey disease. Campbell V; McGrath C; Corry A Br J Dermatol; 2018 May; 178(5):1196-1198. PubMed ID: 28991360 [TBL] [Abstract][Full Text] [Related]
10. Naltrexone for the Treatment of Darier and Hailey-Hailey Diseases. Jfri A; Litvinov IV; Netchiporouk E J Cutan Med Surg; 2019; 23(4):453-454. PubMed ID: 31337235 [No Abstract] [Full Text] [Related]
11. Use of low-dose naltrexone in the treatment of severe Hailey-Hailey disease: One case report. Garayar Cantero M; Canseco Martín M; Aguado García Á; Ruiz-Sánchez D; Valtueña J; Manchado López P Dermatol Ther; 2019 May; 32(3):e12892. PubMed ID: 30958613 [TBL] [Abstract][Full Text] [Related]
13. The uses of naltrexone in dermatologic conditions. Lee B; Elston DM J Am Acad Dermatol; 2019 Jun; 80(6):1746-1752. PubMed ID: 30582992 [TBL] [Abstract][Full Text] [Related]
14. Recalcitrant cases of Hailey-Hailey disease successfully managed with low-dose naltrexone. Vyas HR; Shah SR; Patel HS; Shah BJ Int J Dermatol; 2023 Mar; 62(3):e149-e151. PubMed ID: 35780232 [No Abstract] [Full Text] [Related]
15. Hailey-Hailey disease: the role of azathioprine an immunomodulator. Malan M; Xuejingzi W; Si J; Quan SJ Pan Afr Med J; 2019; 32():65. PubMed ID: 31223357 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of botulinum toxin type A in the treatment of Hailey-Hailey disease. Bagherani N; Smoller BR Dermatol Ther; 2016 Nov; 29(6):394-395. PubMed ID: 26970226 [No Abstract] [Full Text] [Related]
19. Oral glycopyrrolate for the treatment of Hailey-Hailey disease. Kaniszewska M; Rovner R; Arshanapalli A; Tung R JAMA Dermatol; 2015 Mar; 151(3):328-9. PubMed ID: 25651401 [No Abstract] [Full Text] [Related]
20. Hailey-Hailey disease (benign familial pemphigus) responsive to treatment with ocrelizumab for multiple sclerosis. Adamson SR; Higgins CL; Veysey E Br J Dermatol; 2023 Jul; 189(2):232-234. PubMed ID: 37002729 [No Abstract] [Full Text] [Related] [Next] [New Search]